Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 227, Issue 5, Pages 2184-2195
Publisher
Wiley
Online
2011-07-26
DOI
10.1002/jcp.22954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
- (2011) Radhamani Kannaiyan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-γ and COX-2-dependent signals
- (2010) Shing Hwa Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
- (2010) Feng Li et al. CANCER LETTERS
- Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation
- (2010) M. Vaid et al. CARCINOGENESIS
- Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF- B and STAT3 pathways in head and neck cancer cells
- (2010) M. A. Macha et al. CARCINOGENESIS
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
- (2010) R. J. Leeman-Neill et al. CLINICAL CANCER RESEARCH
- Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo
- (2010) Peramaiyan Rajendran et al. CLINICAL CANCER RESEARCH
- Systematic review of hepatocellular adenoma in China and other regions
- (2010) Haoming Lin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2)
- (2010) Junfang Deng et al. LIVER INTERNATIONAL
- Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway byNanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
- (2010) Diana Cirstea et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
- (2010) Fan Yang et al. MOLECULAR CANCER THERAPEUTICS
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
- (2009) Levi E. Fried et al. ANTIOXIDANTS & REDOX SIGNALING
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line
- (2009) Karnati R. Roy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel treatments for hepatocellular cancer
- (2009) S.H. Kerr et al. CANCER LETTERS
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo
- (2009) Cheng Jin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Honokiol-mediated Inhibition of PI3K/mTOR Pathway
- (2009) Courtney Crane et al. JOURNAL OF IMMUNOTHERAPY
- Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
- (2008) Xiaoxia Sun et al. CANCER LETTERS
- Honokiol, a Constituent of Oriental Medicinal Herb Magnolia officinalis, Inhibits Growth of PC-3 Xenografts In vivo in Association with Apoptosis Induction
- (2008) E.-R. Hahm et al. CLINICAL CANCER RESEARCH
- Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells
- (2008) A. Garcia et al. CLINICAL CANCER RESEARCH
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo
- (2008) Esther Raskopf et al. JOURNAL OF HEPATOLOGY
- Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
- (2008) David J. Newman JOURNAL OF MEDICINAL CHEMISTRY
- The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis
- (2008) S. M. Raja et al. MOLECULAR CANCER THERAPEUTICS
- Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models
- (2008) Wenli Hou et al. PHYTOTHERAPY RESEARCH
- Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway
- (2007) Dairmuid M. Moran et al. JOURNAL OF SURGICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started